Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01995981
What this trial is testing

Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS

Who this might be right for
Sarcoma, Soft Tissue
Radboud University Medical Center 22
Not applicableLooking for participantsNCT03853915
What this trial is testing

FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)

Who this might be right for
Cervical Cancer
University Health Network, Toronto 64
Testing effectiveness (Phase 2)Looking for participantsNCT06865768
What this trial is testing

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Who this might be right for
Prostate Carcinoma
Emory University 90
Not applicableUnknownNCT06203613
What this trial is testing

Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

Who this might be right for
Positron Emission TomographyPancreatic NeoplasmsIgestive System Neoplasms
YiHui Guan 40
Not applicableStudy completedNCT01304849
What this trial is testing

Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

Who this might be right for
Hodgkin's Lymphoma
Cancer Institute WIA 50
Early research (Phase 1)Study completedNCT03883776
What this trial is testing

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 12
Not applicableStudy completedNCT06919159
What this trial is testing

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)
Jiequn Yu 45
Not applicableEnded earlyNCT02847468
What this trial is testing

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Who this might be right for
Carcinoma, Hepatocellular
Centre Georges Francois Leclerc 61
Early research (Phase 1)Study completedNCT00959582
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Merck Sharp & Dohme LLC 42
Not applicableLooking for participantsNCT07463625
What this trial is testing

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

Who this might be right for
Cushing DiseaseACTH-producing Pituitary Tumour
Hospices Civils de Lyon 20
Not applicableUnknownNCT04367948
What this trial is testing

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

Who this might be right for
Tumor, SolidPositron-Emission TomographyLymphoma
Peking University Cancer Hospital & Institute 200
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Not applicableStudy completedNCT05346276
What this trial is testing

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

Who this might be right for
PET/CThLAG-3TUMOR
The First Affiliated Hospital of Xiamen University 50
Not applicableLooking for participantsNCT05701176
What this trial is testing

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer

Who this might be right for
Advanced Stage Non-small Cell Lung Cancer
Amsterdam UMC, location VUmc 15
Not applicableUnknownNCT03683550
What this trial is testing

Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma

Who this might be right for
Melanoma
University Hospital, Essen 836
Not applicableNot Yet RecruitingNCT06716788
What this trial is testing

68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy

Who this might be right for
Cancer
Peking University Cancer Hospital & Institute 50
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Not applicableNot Yet RecruitingNCT06916442
What this trial is testing

Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

Who this might be right for
PET/CTSolid Tumors, AdultSolid Tumors, Advanced Solid Tumors
Zhongnan Hospital 200
Large-scale testing (Phase 3)Study completedNCT03353740
What this trial is testing

Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

Who this might be right for
Prostate Cancer
Thomas Hope 346
Very early researchEnded earlyNCT01086696
What this trial is testing

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Who this might be right for
Breast CancerLung CancerRenal Cancer+1 more
National Cancer Institute (NCI) 6
Next Page